How were Therapix Biosciences' earnings last quarter?

Therapix Biosciences Ltd. (NASDAQ:TRPX) issued its quarterly earnings results on Monday, August, 20th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.59) by $0.24.

What other stocks do shareholders of Therapix Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Therapix Biosciences investors own include Zynerba Pharmaceuticals (ZYNE) , Cara Therapeutics (CARA) , GW Pharmaceuticals (GWPH) , SCYNEXIS (SCYX) , Sangamo Therapeutics (SGMO) , Tilray (TLRY) , Corbus Pharmaceuticals (CRBP) and VBI Vaccines (VBIV) .

NASDAQ:TRPX

Therapix Biosciences (TRPX) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free TRPX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.09
▼
$0.12
50-Day Range: $0.10
▼
$0.32
52-Week Range: $0.25
▼
$4.69

Volume: 95,212 shs
Average Volume: 1.59 million shs
Market Capitalization: $351,000.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Therapix Biosciences alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

TRPX Stock News Headlines

December 12, 2023 | benzinga.com

Anixa Biosciences Stock (NASDAQ:ANIX), Analyst Ratings, Price Targets, Predictions

August 23, 2023 | investing.com

Sagimet Biosciences Inc (SGMT)

April 19, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

August 1, 2023 | seekingalpha.com

PBIO Pressure BioSciences, Inc.

January 19, 2022 | thestreet.com

Cannabis, Coats, and Social Media: The Good, Bad, and Ugly of 2017's IPOs

See More Headlines

Receive TRPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapix Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/20/2018
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:TRPX
CUSIP: N/A
CIK: 1611746
Web: therapixbio.com
Phone: 972-3616-7055
Fax: N/A
Employees: 9
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 3,510,000
Free Float: N/A
Market Cap: $351,000.00
Optionable: Not Optionable
Beta: N/A

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Dr. Ascher Shmulewitz (Age 63)
Chairman & Interim CEO
Dr. Adi Zuloff-Shani (Age 51)
Chief Technology Officer
Mr. Oz Adler CPA (Age 32)
Chief Financial Officer

Key Competitors

View All Competitors

TRPX Stock Analysis - Frequently Asked Questions

How were Therapix Biosciences' earnings last quarter?: Therapix Biosciences Ltd. (NASDAQ:TRPX) issued its quarterly earnings results on Monday, August, 20th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.59) by $0.24.
What other stocks do shareholders of Therapix Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Therapix Biosciences investors own include Zynerba Pharmaceuticals (ZYNE), Cara Therapeutics (CARA), GW Pharmaceuticals (GWPH), SCYNEXIS (SCYX), Sangamo Therapeutics (SGMO), Tilray (TLRY), Corbus Pharmaceuticals (CRBP) and VBI Vaccines (VBIV).

This page (NASDAQ:TRPX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Therapix Biosciences (TRPX) Stock Price, News & Analysis

TRPX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

TRPX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info